Second curettage for treatment of low-risk gestational trophoblastic neoplasia: A cost-effectiveness analysis

被引：0
|
作者：
Batman, S. [1 ]
Allen, A. J. [1 ]
Skeith, A. E. [1 ]
Caughey, A. B. [1 ]
Bruegl, A. S. [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
GYNECOLOGIC ONCOLOGY | 2019年 / 154卷
关键词：
D O I：
10.1016/j.ygyno.2019.04.445
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2216
引用
收藏
页码：192 / 192
页数：1
相关论文
共 50 条
  • [31] OUTCOME OF LOW-RISK GESTATIONAL TROPHOBLASTIC NEOPLASIA (GTN) TREATED WITH METHOTREXATE
    Alobaid, A.
    Ahmeed, S.
    Saleh, R.
    Mattar, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [32] Eight days versus weekly intramuscular methotrexate for the treatment of low-risk gestational trophoblastic neoplasia
    Anfinan, N. M.
    Al Khatieb, M. T.
    Sait, H. K.
    Sait, M. K.
    Baghlaf, O. A.
    Mousa, A. A.
    Sait, K. H.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2020, 41 (02) : 227 - 232
  • [33] Pulse methotrexate versus pulse actinomycin D in the treatment of low-risk gestational trophoblastic neoplasia
    Yarandi, Fariba
    Eftekhar, Zahra
    Shojaei, Hadi
    Kanani, Soheyla
    Sharifi, Ali
    Hanjani, Parviz
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2008, 103 (01) : 33 - 37
  • [34] SINGLE-DOSE METHOTREXATE IN THE TREATMENT OF LOW-RISK GESTATIONAL TROPHOBLASTIC NEOPLASIA - AN UPDATED RESULTS
    Ngu, S. F.
    Tse, K. Y.
    Chu, M. Y. M.
    Sheung, P. N. H.
    Chan, K. L. K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A140 - A140
  • [35] Risk factors for second-line dactinomycin failure after methotrexate treatment for low-risk gestational trophoblastic neoplasia: a retrospective study
    Hoeijmakers, Y. M.
    Sweep, F. C. G. J.
    Lok, C. A. R.
    Ottevanger, P. B.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2020, 127 (09) : 1139 - 1145
  • [36] Comment on single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia
    Mahajan, Niraj N.
    Soni, Rajani N.
    Mahajan, Kshitija N.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (03) : 325 - 325
  • [37] 5-Fluorouracil as first-line treatment for low-risk gestational trophoblastic neoplasia
    Chen, Dan
    Yang, Yanfeng
    Li, Yitong
    Zhao, Yining
    Zhang, Xin
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (12) : 2677 - 2684
  • [38] Efficacy of Combination Therapy with Actinomycin D and Methotrexate in the Treatment of Low-Risk Gestational Trophoblastic Neoplasia
    Kang, Hai-Li
    Zhao, Qun
    Yang, Shu-Li
    Duan, Wei
    CHEMOTHERAPY, 2019, 64 (01) : 42 - 47
  • [39] The diagnostics and treatment of low-risk gestational trophoblastic neoplasia (GTN): 42-year experience
    Fulop, Vilmos
    Szigetvari, Ivan
    Szepesi, Janos
    Lahm, Erika
    Vegh, Gyorgy
    Demeter, Janos
    Papai, Zsuzsanna
    Berkowitz, Ross S.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (06) : 1159 - 1165
  • [40] Effectiveness and toxicity of second-line actinomycin D in patients with methotrexate-resistant postmolar low-risk gestational trophoblastic neoplasia
    Maesta, Izildinha
    Nitecki, Roni
    Freitas Desmarais, Cecilia Canedo
    Horowitz, Neil S.
    Goldstein, Donald P.
    Elias, Kevin M.
    Berkowitz, Ross S.
    GYNECOLOGIC ONCOLOGY, 2020, 157 (02) : 372 - 378
12345